Mario Gabelli's RNA Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 3,500 shares of Avidity Biosciences, Inc. (RNA) worth $252,455, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Mario Gabelli has initiated a new position in RNA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Avidity Biosciences (RNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avidity Biosciences (RNA) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3,500 | New Buy | 3,500 | $72.13 |
Mario Gabelli's Avidity Biosciences Investment FAQs
Mario Gabelli first purchased Avidity Biosciences, Inc. (RNA) in Q4 2025, acquiring 3,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Avidity Biosciences, Inc. (RNA) for 1 quarters since Q4 2025.
Mario Gabelli's largest addition to Avidity Biosciences, Inc. (RNA) was in Q4 2025, adding 3,500 shares worth $252,455.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 3,500 shares of Avidity Biosciences, Inc. (RNA), valued at approximately $252,455.
As of the Q4 2025 filing, Avidity Biosciences, Inc. (RNA) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Avidity Biosciences, Inc. (RNA) was 3,500 shares, as reported at the end of Q4 2025.